IE
EXAS

Israel Englander’s Exact Sciences EXAS Stock Holding History

Israel Englander’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-60,000
Closed -$3.19M – 6145
2025
Q2 		$3.19M Buy
60,000
+54,100
+917% +$2.75M ﹤0.01% 3442
2025
Q1 		$255K Sell
5,900
-24,000
-80% -$1.22M ﹤0.01% 5179
2024
Q4 		$1.68M Buy
29,900
+6,800
+29% +$423K ﹤0.01% 3781
2024
Q3 		$1.57M Sell
23,100
-1,900
-8% -$107K ﹤0.01% 3919
2024
Q2 		$1.06M Sell
25,000
-120,300
-83% -$6.62M ﹤0.01% 4077
2024
Q1 		$10M Buy
145,300
+127,100
+698% +$8.04M ﹤0.01% 2190
2023
Q4 		$1.35M Sell
18,200
-106,400
-85% -$6.97M ﹤0.01% 3929
2023
Q3 		$8.5M Buy
124,600
+75,300
+153% +$6.39M ﹤0.01% 2200
2023
Q2 		$4.63M Buy
+49,300
New +$3.85M ﹤0.01% 2749
2019
Q2 		– Sell
-30,000
Closed -$2.6M – 4154
2019
Q1 		$2.6M Buy
+30,000
New +$2.55M ﹤0.01% 2228

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Israel Englander's EXAS Position: Q1 2026 in Review

Israel Englander sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 3,441,516 shares — an estimated $350M sold.

Israel Englander first reported a position in EXAS in Q2 2013 and held it in 44 quarters. The position peaked at $350M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Israel Englander reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Israel Englander sold 3,441,516 Exact Sciences shares in Q1 2026, an estimated $350M.
  • Israel Englander first reported a position in Exact Sciences in Q2 2013 and held it in 44 quarters.
  • Israel Englander's Exact Sciences position peaked at $350M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.